NANOFORM
They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’ problems.Their mission is to support pharma companies as they develop life-changing medicines, by overcoming drug development & delivery challenges.
NANOFORM
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2015-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.nanoform.fi
Total Employee:
11+
Status:
Active
Contact:
358 29 370 0150
Email Addresses:
[email protected]
Total Funding:
42 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS WPForms CodeTwo Shortcodes Ultimate
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Current Employees Featured
Founder
Stock Details
Investors List
Mandatum Life Insurance Company
Mandatum Life Insurance Company investment in Venture Round - Nanoform
Ilmarinen Mutual Pension Insurance Company
Ilmarinen Mutual Pension Insurance Company investment in Venture Round - Nanoform
Official Site Inspections
http://www.nanoform.fi
- Host name: 172.67.138.171
- IP address: 172.67.138.171
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nanoform"
Nanoform - LinkedIn
Helsinki, Southern Finland 00790, FI Get directions Employees at Nanoform ... Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and ...See details»
Nanoform - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 358 29 370 0150 They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’ problems.Their …See details»
Nanoform – Wikipedia
Nanoform Finland Oyj on suomalainen lääkekehitysyhtiö. Toukokuussa 2020 Nanoform kertoi aikeistaan listautua Helsingin ja Tukholman pörssien First North-listoille. [1] Kesäkuussa 2020 …See details»
ABOUT NANOFORM - PHARMACEUTICAL ONLINE
Nanoform works together with pharma and biotech partners to improve the lives of patients globally by overcoming drug development and delivery challenges through its game-changing nanoforming technologies, novel formulation …See details»
Nanoform - pharmaceutical-tech.com
Cultivator II, Viikinkaari 4 FI-00790 Helsinki Finland. Products; Catalogues; Press Release; White Papers; Videos; Profile. About Nanoform . Visit Website. ... (CESS®) process in 2012 at the …See details»
Nanoform - ONdrugDelivery
Headquarters Nanoform Finland Oyj Cultivator II Viikinkaari 4 FI-00790 Helsinki Finland . Phone / Contact. T: +358 29 370 0150 E: [email protected] ... Nanoform shares are publicly traded on …See details»
About Nanoform – Nanoform small is powerful
Since then, Nanoform has expanded rapidly, transforming into a company with global ambition. Our cutting edge nanoforming services is intended to help the global pharmaceutical industry to double its annual new medicines output. We …See details»
Nanoform - BioTechniques
Address: Cultivator II, Viikinkaari 4, FI-00790 Helsinki, Finland Watch Christian Jones, Chief Commercial Officer at Nanoform (Helsinki, Finland), discuss some of the challenges that exist …See details»
Nanoform Finland Oyj Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nanoform Finland Oyj of HELSINKI, Uusimaa. Get the latest business insights from Dun & Bradstreet.See details»
Nanoform - Org Chart, Teams, Culture & Jobs - The Org
View Nanoform's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Nanoform Company Profile - Office Locations, Competitors ... - Craft
Nanoform has 5 employees at their 1 location and $19.53 m in total funding,. See insights on Nanoform including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
The Hub | Nanoform
Nanoform.fi: Founded: 2015: Employees: 11-50: Industries: Healthcare & Life Science, SaaS: Business model-Funding state-Claim startup We connect global talents with career …See details»
Investors – Nanoform small is powerful
Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. ... FI-00790 Helsinki …See details»
Corporate Governance – Nanoform small is powerful
The corporate governance and management in Nanoform is based on Finnish legislation, Nasdaq First North Growth Market Rulebook, the Finnish Corporate Governance Code, the company’s …See details»
The Board of Directors – Nanoform small is powerful
The Board of Directors is the Company’s highest decision-making body after the General Meeting. Nanoform’s Board of Directors is responsible for the management of the Company and for the …See details»
About the website – Nanoform small is powerful
Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. ... FI-00790 Helsinki …See details»
Technologies and services – Nanoform small is powerful
Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. ... FI-00790 Helsinki …See details»
Nanoform Q1 2025 report: Deal mosaic emerge and commercial …
1 day ago Nanoform Finland Plc | Company Release | May 20, 2025 at 08:10:00 EEST. Term sheets agreed for several key markets around nanoenzalutamide 1).First term sheet also …See details»
PÖRSSI: Helsingin pörssi hakee suuntaa – Nanoform ja Konecranes ...
23 hours ago Terveysteknologiayhtiö Nanoform julkisti ensimmäisen kvartaalin tuloksensa tiistaina aamulla. Yhtiön liikevaihto kasvoi tammi–maaliskuussa. Käyttökate koheni, mutta oli …See details»
Media Center – Nanoform small is powerful
May 5, 2025 Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. ... FI …See details»